Skip to main content

14 Result(s)

within J. -F. Seitz Remove this filter

and

  1. No Access

    Article

    Hommage à Franck Bonnetain

    I. Krakowski, F. Joly, C. Louvet, D. Malka, J. -F. Seitz in Oncologie (2017)

  2. No Access

    Article

    Quel traitement adjuvant de l’adénocarcinome du pancréas aujourd’hui : quelles perspectives ?

    Avec une mortalité proche de l’incidence, le cancer du pancréas a un taux de survie globale à cinq ans autour de 5 %. C’est le sixième cancer le plus fréquent en France (11 600 nouveaux cas annuels en 2012) et...

    J.-F. Seitz, C. Sibertin-Blanc, E. Norguet, L. Dahan in Oncologie (2015)

  3. No Access

    Article

    Traitement adjuvant du cancer colorectal : l’aspirine, une biothérapie ciblée ?

    Malgré l’efficacité des chimiothérapies adjuvantes dans le cancer colorectal (CCR), la moitié des patients ayant reçu une chirurgie à visée curative vont présenter une récidive. Il paraît donc essentiel de tro...

    C. Sibertin-Blanc, L. Dahan, P. Michel, J.-F. Seitz in Oncologie (2014)

  4. Article

    Open Access

    Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

    This trial evaluated the feasibility and efficacy of combined sorafenib and irinotecan (NEXIRI) as second- or later-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC), who had progre...

    E Samalin, O Bouché, S Thézenas, E Francois, A Adenis… in British Journal of Cancer (2014)

    Download PDF (272 KB) View Article

  5. No Access

    Article

    Comment surveiller les patients opérés à visée curative d’un cancer colorectal ?

    Malgré leur fréquence, les modalités de surveillance des cancers colorectaux opérés à visée curative restent mal codifiées. La place respective du scanner thoracoabdominopelvien, de l’échographie hépatique et ...

    C. Lepage, L. Dahan, L. Bedenne, J. -F. Seitz in Côlon & Rectum (2009)

  6. Article

    Open Access

    Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

    This dose escalation study was designed to determine the maximum tolerated dose (MTD) and recommended doses (RDs) of 5-fluorouracil (5FU), folinic acid and oxaliplatin (FOLFOX) with concomitant radiotherapy in...

    T Conroy, F Viret, E François, J F Seitz, V Boige, M Ducreux… in British Journal of Cancer (2008)

    Download PDF (178 KB) View Article

  7. Article

    Open Access

    ‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

    This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT®)/leucovorin (LV) and oxaliplatin in patients (pts) with metastatic colorectal cancer (MCRC...

    J Bennouna, H Perrier, B Paillot, F Priou, J H Jacob, M Hebbar… in British Journal of Cancer (2006)

    Download PDF (132 KB) View Article

  8. No Access

    Article

    Actualité de l’ASCO 2004 par localisations

    L. Dahan, J.-F. Seitz in ONCOLOGIE (2004)

  9. Article

    Open Access

    Carcinoma of the oesophagus

    J F Seitz, A Sarradet, E François, J H Jacob, J M Ollivier… in British Journal of Cancer (2001)

    Download PDF (206 KB)

  10. No Access

    Article

    Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1

    The human CCND1/PRAD1 gene, located in the 11q13 chromosomal region, encodes a cyclin D protein with potential oncogenic capacity and is involved in several human malignancies. The amplification and expression...

    J Adélaide, G Monges, C Dérdérian, J-F Seitz, D Birnbaum in British Journal of Cancer (1995)

  11. Article

    Echoendoscopie sectorielle électronique en pathologie bilio-pancréatique — résultats d’une série de 88 patients

    Le but de ce travail est d’évaluer, en pathologie bilio-pancréatique, les résultats d’un nouveau type d’échoendoscope à balayage sectoriel électronique réalisant des coupes sagittales de 120°. D’octobre 1991 à...

    M. Giovannini, J. F. Seitz in Acta Endoscopica (1994)

    Download PDF (5021 KB)

  12. No Access

    Article

    Quelle est la place de l’endoscopie digestive dans le diagnostic initial et la surveillance des lymphomes malins non hodgkiniens?

    L’endoscopie digestive joue un räle essentiel dans lediagnostic ou le bilan d’extension initial, et dans lasurveillance des lymphomes malins non hodgkiniens.

    J. F. Seitz, M. Giovannini, B. Seitz, G. Monges, Y. Carcassonne in Acta Endoscopica (1989)

  13. No Access

    Chapter and Conference Paper

    Restriction Fragment Length Polymorphism of the c-Ha-ras-1 Proto-Oncogene as a Marker of Genome Alterations and Susceptibility to the Development of Some Human Carcinomas

    The c-Ha-ras-1 proto-oncogene is highly polymorphic in a human population. A restriction fragment length polymorphism (RFLP) of FLa-ras, identified by a set of restriction endonucleases (BamHI, MspI, TaqI) was as...

    P. G. Knyazev, I. F. Nikiforova, O. M. Serova… in Modern Trends in Human Leukemia VIII (1989)

  14. No Access

    Chapter and Conference Paper

    Molecular-Genetic Analysis of myc and c-Ha-ras Proto-oncogene Alterations in Human Carcinoma

    The results of recent studies on the molecular biology of cancer suggest the abnormal expression of cellular proto-oncogenes in the process of carcinogenesis [1]. The activation of proto-oncogenes, i.e., their...

    P. G. Knyazev, S. N. Fedorov, O. M. Serova… in Modern Trends in Human Leukemia VII (1987)